Cellular and Molecular Neuroscience journals by time to acceptance (2025)

44 journals with 2025 figures · median days from submission to acceptance, measured from PubMed dates · data as of Sep 15, 2026

Sorted by median days from submission to acceptance in 2025. Faster is not better — this is a planning aid, not a ranking of quality. Click a column to re-sort.

2025 figures only
Open access
Peptides65 (47–88)601≈$3,7100.0
Frontiers in Cellular Neuroscience67 (48–91)23820≈$3,850Open access (DOAJ)0.9
Journal of Molecular Neuroscience68 (47–102)15917≈$4,9901.5
Journal of Neural Transmission72 (46–121)20519≈$4,690Hybrid0.0
Frontiers in Neural Circuits79 (63–141)5719≈$3,850Open access (DOAJ)0.0
Molecular Brain80 (55–118)9516$2,890Open access (DOAJ)0.0
Journal of the Peripheral Nervous System84 (50–117)84≈$4,5500.0
Neurochemical Research85 (62–129)31416≈$4,5900.73
Neurochemistry International87 (64–120)1341≈$4,1700.0
Life Sciences89 (67–117)5853≈$3,810Hybrid6.52
Neuroscience Letters89 (58–120)2191≈$3,430Hybrid0.0
Neuroscience Research90 (59–125)952$3,250Open access (DOAJ)0.0
Pharmacology Biochemistry and Behavior92 (61–160)1053≈$3,6500.0
Trends in Neurosciences92 (16–117)9924≈$7,0300.0
Pharmacological Reports93 (66–129)12111≈$3,2901.72
Neuropharmacology94 (69–132)3632≈$4,300Hybrid0.0
Journal of Neuroscience Methods95 (69–133)2172≈$3,900Hybrid0.0
Experimental Neurology101 (77–133)3622≈$4,110Hybrid0.0
Brain Research Bulletin105 (76–149)4672$3,610Open access (DOAJ)3.58
Journal of Pharmacology and Experimental Therapeutics107 (75–153)2237≈$3,750Hybrid0.0
Fluids and Barriers of the CNS108 (79–144)13120$3,490Open access (DOAJ)0.0
Neuropsychopharmacology109 (81–143)24716≈$5,290Hybrid0.0
Cellular and Molecular Neurobiology111 (79–163)12722≈$4,5900.0
Cell and Tissue Research112 (80–160)8218≈$5,2901.55
The Journal of Physiology113 (50–170)61324≈$5,400Hybrid0.0
Brain Research115 (79–164)4652≈$3,3602.19
Neuroscience118 (83–164)6712≈$3,500Hybrid0.43
European Journal of Pharmacology122 (90–162)1,0091≈$3,2300.0
Current Opinion in Neurobiology127 (92–173)13527≈$4,320Hybrid0.0
eNeuro131 (82–200)26338$3,690Open access (DOAJ)0.0
Journal of Neurochemistry133 (82–183)307≈$5,3300.0
Addiction Biology139 (72–196)100$3,460Open access (DOAJ)0.0
Psychopharmacology140 (84–198)24719≈$4,390Hybrid0.0
Progress in Neurobiology160 (123–209)852≈$5,190Hybrid0.0
European Journal of Neuroscience162 (118–230)368≈$3,560Hybrid0.0
Glia173 (124–230)13015≈$5,4500.0
Journal of Neuroscience175 (125–251)65459Hybrid0.61
The Journal of Comparative Neurology178 (121–226)91≈$5,4500.0
BMC Neuroscience179 (131–258)6314$2,990Open access (DOAJ)0.0
The Journal of General Physiology179 (103–293)5327Hybrid0.0
Journal of Neuroscience Research182 (132–263)84≈$4,8400.0
Hippocampus189 (97–259)58≈$4,7800.0
Neuron211 (84–298)35029≈$10,400Hybrid0.0
Nature Neuroscience451 (350–614)20853≈$12,690Hybrid0.0

Journals are listed where at least 25% of their articles' topics fall in Cellular and Molecular Neuroscience (OpenAlex).

Latest available year: 2024

4 journals without enough usable 2025 data. Their 2024 figures are shown separately so they are never compared with 2025 figures.

2024 figures only
Open access
Neuropeptides63 (49–97)542≈$3,5303.97
Frontiers in Neuroanatomy66 (53–81)6719≈$3,850Open access (DOAJ)0.0
Reviews in the Neurosciences73 (55–104)5024≈$2,712Hybrid0.0
Learning & Memory125 (90–167)5356Open access0.0

Latest available year: 2023

2 journals without enough usable 2025 data. Their 2023 figures are shown separately so they are never compared with 2025 figures.

2023 figures only
Open access
Journal of Chemical Neuroanatomy85 (53–104)1002≈$3,23035.03
Molecular and Cellular Neuroscience96 (72–132)645≈$3,4500.0

Latest available year: 2022

2 journals without enough usable 2025 data. Their 2022 figures are shown separately so they are never compared with 2025 figures.

2022 figures only
Open access
Frontiers in Synaptic Neuroscience58 (37–79)6627≈$3,850Open access (DOAJ)
Neurotoxicity Research88 (57–121)15614≈$4,5900.0

Latest available year: 2020

1 journal without enough usable 2025 data. Their 2020 figures are shown separately so they are never compared with 2025 figures.

2020 figures only
Open access
Developmental Neurobiology140 (84–188)5925≈$4,550

Have a deadline?

Pick up to five journals and see whether a submission sequence can realistically reach acceptance before your defence, visa or job-market date. Free.

Open the submission planner

Frequently asked questions

Which Cellular and Molecular Neuroscience journals accepted papers fastest in 2025?

Among 44 Cellular and Molecular Neuroscience journals with enough dated articles in 2025, the shortest median time from submission to acceptance was 65 days (Peptides). The middle journal's median was 111 days. Speed is not a measure of quality; check scope, indexing and fees too.

How are these times measured?

From the submission and acceptance dates publishers deposit in PubMed, for accepted articles only. Each journal needs at least 50 dated articles in the year shown, and a table headed with a year contains only that year's figures.

Get the free Journal Submission Go/No-Go Checklist

The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.

One email with your download, then occasional research tips. One-click unsubscribe, anytime. We never sell your data.

Get Write and Publish a Scientific Paper

Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.